My ePortfolio Register   

Immunotherapy for gastric cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.01.17
Views: 710
Rating:

Prof Yung-Jue Bang - Seoul National University College of Medicine, South Korea

Dr Bang meets with ecancertv at the Immuno-Oncology Hong Kong 2016 meeting to discuss the current status, and future developments, of immunotherapy for treating gastric cancers.

He considers PD-1 as biomarker for patient selection and guiding treatment, with ongoing clinical trials to determine its utility.

Dr Bang last spoke with ecancer at ESMO 2016, discussing olaparib and paclitaxel to treat relapsed gastric cancer.

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence